Home PI3K/Akt/mTOR Antineoplastic and Immunosuppressive Antibiotics Remmer Honokiol

alleen voor onderzoeksdoeleinden

Honokiol Antineoplastic and Immunosuppressive Antibiotics Remmer

Cat.nr.: S2310

Honokiol is het actieve bestanddeel van magnolia-extract dat Akt-fosforylering remt en ERK1/2-fosforylering bevordert. Deze verbinding veroorzaakt G0/G1-fase-arrestatie, induceert apoptose en autophagy via de ROS/ERK1/2-signaleringsroute. Het remt hepatitis C virus (HCV)-infectie. Fase 3.
Honokiol Antineoplastic and Immunosuppressive Antibiotics Remmer Chemical Structure

Chemische structuur

Molecuulgewicht: 266.334

Spring naar

Kwaliteitscontrole (Quality Control)

Batch: Zuiverheid: 99.96%
99.96

Celkweek, behandeling & werkzame concentratie
(Cell Culture, Treatment & Working Concentration)

Cellijnen Assaytype Concentratie Incubatietijd Formulering Activiteitsbeschrijving PMID
human UACC-903 cells Cytotoxicity assay Cytotoxicity against human UACC-903 cells after 72 hrs by MTS assay, IC50=5.1 μM
Vero E6 cells Function assay Antiviral activity against SARS coronavirus in Vero E6 cells assessed as inhibition of viral replication by ELISA, EC50=6.5 μM
human UACC-903 cells Cytotoxicity assay Cytotoxicity against human UACC-903 cells after 24 hrs by MTS assay, IC50=7.45 μM
human A549 cells Cytotoxicity assay Cytotoxicity against human A549 cells after 72 hrs by MTS assay, IC50=7.75 μM
human CEM cells Cytotoxicity assay Cytotoxicity against human CEM cells, IC50=10.9 μM
HEK293 cells Function assay Agonist activity at RXRalpha in HEK293 cells assessed as transcriptional activation after 48 hrs by luciferase reporter gene assay, EC50=11.8 μM
human A549 cell Cytotoxicity assay 24 h Cytotoxicity against human A549 cells after 24 hrs by MTS assay, IC50=12.51 μM
human HT-29 cells Cytotoxicity assay 72 h Cytotoxicity against human HT-29 cells after 72 hrs by MTS assay, IC50=13.24 μM
human PBM cells Cytotoxicity assay Cytotoxicity against human PBM cells, IC50=16.1 μM
Hep-G2 cells Cytotoxicity assay Cytotoxicity of compound against human liver tumor cell line (Hep-G2) was determined, IC50=16.5 μM
human HepG2 cells Proliferation assay 24 h Antiproliferative activity against human HepG2 cells after 24 hrs by MTT assay, IC50=16.5 μM
human K562 cells Proliferation assay Antiproliferative activity against human K562 cells by MTT assay, IC50=21.1 μM
Vero cells Cytotoxicity assay Cytotoxicity against Vero cells, IC50=22.5 μM
human A2780 cells Proliferation assay Antiproliferative activity against cisplatin-sensitive human A2780 cells by MTT assay, IC50=30.5 μM
human SPC-A1 cells Proliferation assay Antiproliferative activity against human SPC-A1 cells by MTT assay, IC50=36.1 μM
HUVEC cells Function assay 20 μM 24 h Antimigratory activity against human HUVEC cells at 20 uM after 24 hrs by wound-healing assay
HEK293 cells Function assay 24-48 h Agonist activity at human RXR-alpha expressed in HEK293 cells coexpressing with pCMX-beta-gal after 24 to 48 hrs by luciferase reporter gene assay
human SH-SY5Y cells Function assay 10 μM 30 mins Neuroprotective activity in human SH-SY5Y cells assessed as inhibition of CHP and TBHP-induced cell death at 10 uM incubated for 30 mins prior to challenge measured after 3 hrs by MTT assay
Klik om meer experimentele gegevens over cellijnen te bekijken

Chemische informatie, opslag en stabiliteit (Chemical Information, Storage & Stability)

Molecuulgewicht 266.334 Formule

C18H18O2

 Opslag (vanaf de datum van ontvangst)
CAS-nr. 35354-74-6 SDF downloaden Opslag van stamoplossingen

Synoniemen NSC 293100 Smiles C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C

Oplosbaarheid (Solubility)

In vitro
Batch:

DMSO : 53 mg/mL (198.99 mM)
(Met vocht verontreinigd DMSO kan de oplosbaarheid verminderen. Gebruik verse, watervrije DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molariteitscalculator

Massa Concentratie Volume Molecuulgewicht
Verdunningscalculator Molecuulgewichtcalculator

In vivo
Batch:

In vivo formulatiecalculator (heldere oplossing)

Stap 1: Voer onderstaande informatie in (Aanbevolen: een extra dier om rekening te houden met verlies tijdens het experiment)

mg/kg g μL

Stap 2: Voer de in vivo formulering in (Dit is alleen de calculator, geen formulering. Neem eerst contact met ons op als er geen in vivo formulering is in de sectie oplosbaarheid.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Berekeningsresultaten:

Werkconcentratie: mg/ml;

Methode voor het bereiden van DMSO-moedervloeistof: mg geneesmiddel vooropgelost in μL DMSO ( Concentratie moedervloeistof mg/mL, Neem eerst contact met ons op als de concentratie de DMSO-oplosbaarheid van de batch van het geneesmiddel overschrijdt. )

Methode voor het bereiden van in vivo formulering: Neem μL DMSO moedervloeistof, voeg daarna toeμL PEG300, mengen en verhelderen, daarna toevoegenμL Tween 80, mengen en verhelderen, daarna toevoegen μL ddH2O, mengen en verhelderen.

Methode voor het bereiden van in vivo formulering: Neem μL DMSO moedervloeistof, voeg daarna toe μL Maïsolie, mengen en verhelderen.

Opmerking: 1. Zorg ervoor dat de vloeistof helder is voordat u het volgende oplosmiddel toevoegt.
2. Zorg ervoor dat u het/de oplosmiddel(en) in de juiste volgorde toevoegt. U moet ervoor zorgen dat de verkregen oplossing, bij de vorige toevoeging, een heldere oplossing is voordat u verdergaat met het toevoegen van het volgende oplosmiddel. Fysieke methoden zoals vortexen, ultrasoon of een warmwaterbad kunnen worden gebruikt om het oplossen te bevorderen.

Werkingsmechanisme (Mechanism of Action)

Targets/IC50/Ki
Akt-phosphorylation
MEK
In vitro

Honokiol shows pro-apoptotic effects in melanoma, sarcoma, myeloma, leukemia, bladder, lung, prostate, oral squamous cell carcinoma and colon cancer cell lines. This compound is effective on inducing apoptosis in SVR angiosarcoma cells. Treatment of SVR cells with this chemical causes decreased phosphorylation of MAP kinase, akt, and c-src. In addition, it potentiates TRAIL-mediated apoptosis, and its cytotoxicity is partially abrogated by neutralizing antibodies to TRAIL. This compound also has direct antiangiogenic activity, in that it blocks the phosphorylation and rac activation due to VEGF-VEGFR2 interactions. It causes apoptosis in CLL cells through activation of caspase 8, followed by caspase 9 and 3 activation. This chemical prevents interleukin-4-mediated survival of CLL cells, and potentiats the cytotoxicity of CB-1348, FaraA, and 2-CdA. It kills myeloma cells from relapsed patients at doses that does not kill PBMCs. Caspase 3, 7, 8, and 9 are induced by this compound treatment, as well as PARP cleavage. It is found to induce apoptosis in the colon cancer cell lines RKO. This chemical potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. It may act as a potent anti-inflammatory agent with multipotential activities due to an inhibitory effect on the PI3K/Akt pathway.

In vivo

Honokiol is highly effective against SVR angiosarcoma in nude mice. This compound inhibits the growth of RKO cells in murine xenografts. It prevents the growth of MDA-MD-231 breast cancer cells in murine xenografts.

Referenties
  • [4] https://pubmed.ncbi.nlm.nih.gov/15259066/
  • [5] https://pubmed.ncbi.nlm.nih.gov/16966432/
  • [6] https://pubmed.ncbi.nlm.nih.gov/18158873/
  • [7] https://pubmed.ncbi.nlm.nih.gov/17487375/
  • [8] https://pubmed.ncbi.nlm.nih.gov/15922325/

Toepassingen (Applications)

Methoden Biomarkers Afbeeldingen PMID
Western blot p-EGFR / p-AKT / p-STAT3 / p-ERK / p-GSK3α/β / Bax / p-pRb / p-BAD / IκBα / CDK2 / CDK4 / Cyclin D1 p-Lyn / Lyn / p-PI3K
S2310-WB1
27458163
Immunofluorescence Vimentin / Occludin IκBα / NF-κB p65
S2310-IF1
24508063